World’s first migraine-specific prevention treatment available in Singapore
Drug Discovery | News | 0 Comment | 22 Nov, 2018
Singapore – Novartis announced that the Health Sciences Authority (HSA) has approved Aimovig (erenumab) ...Read more
OBI Pharma granted FDA ODD for OBI-888
Drug Discovery | News | 0 Comment | 21 Nov, 2018
OBI Pharma, Inc., a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) h...Read more
Exscientia acquires Kinetic Discovery to build 'full stack' AI-driven drug discovery capabilities
Drug Discovery | News | 0 Comment | 15 Nov, 2018
Singapore - Exscientia, the company leading the use of Artificial Intelligence (AI) in drug discovery, announces that is...Read more
MEI Pharma, KHK to develop and commercialize ME-401
Drug Discovery | News | 0 Comment | 05 Nov, 2018
MEI Pharma, Inc. and Kyowa Hakko Kirin Co., Ltd. (KHK), have announced the execution of a license agreement granting KHK...Read more
FDA OKs J&J's Invokana for heart conditions
Drug Discovery | News | 0 Comment | 31 Oct, 2018
Singapore – The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and D...Read more
Halozyme licenses $25M drug delivery technology to Roche
Drug Discovery | News | 0 Comment | 30 Oct, 2018
Singapore – Halozyme has out-licensed its ENHANZE drug delivery technology to Roche for the exclusi...Read more
Pfizer, Eli Lilly’s non-opioid drug helps reduce osteoarthritis pain
Drug Discovery | News | 0 Comment | 24 Oct, 2018
Singapore – A non-opioid drug developed by Pfizer and Eli Lilly met the main go...Read more
FDA approves Regeneron, Sanofi's Dupixent for asthma treatment
Drug Discovery | News | 0 Comment | 22 Oct, 2018
Singapore - The FDA approves Regeneron Pharmaceuticals and development partner Sanofi's DUPIXENT (dupilumab) a...Read more
Roche's Tecentriq extends progression-free survival in TNBC
Drug Discovery | News | 0 Comment | 22 Oct, 2018
Singapore - Results from a Phase 3 clinical trial, IMpassion130, evaluating Roche unit Genentech's TECENTRIQ (...Read more
Ostrich antibody as dengue fever solution ready for commercialization
Drug Discovery | News | 0 Comment | 22 Oct, 2018
Singapore - MAZ World and ZEAL Cosmetics have confirmed that Ostrich Antibodies are effective in neutralising all four s...Read more
Strides Pharma gets USFDA nod for its anti-epileptic drug
Drug Discovery | News | 0 Comment | 22 Oct, 2018
Strides Pharma Science (Strides) on Saturday announced that its global arm Strides Pharma Global Pte Singapore has recei...Read more
Eisai discovers new compound to treat Parkinson's disease
Drug Discovery | News | 0 Comment | 19 Oct, 2018
A joint research group centered around Professor Hideyuki Okano and Associate Professor Jun Kohyama, Department of Physi...Read more
Axsome receives FDA Orphan Drug designation for narcolepsy drug
Drug Discovery | News | 0 Comment | 17 Oct, 2018
Singapore - Axsome Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for the mana...Read more
FDA issues new guidance for developers of complex generics
Drug Discovery | News | 0 Comment | 10 Oct, 2018
Singapore - The FDA has released new guidance documents aimed at advancing development of generic versio...Read more
Novartis’ crizanlizumab relieves patients from sickle cell pain crisis
Drug Discovery | News | 0 Comment | 10 Oct, 2018
Results from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab, a humanized anti-P-selectin monoclonal ...Read more
J&J abandons partnership for Geron’s cancer drug
Drug Discovery | News | 0 Comment | 04 Oct, 2018
Singapore - Johnson & Johnson has dissolved its four-year-old partnership with Geron for cancer drug imetelstat...Read more
New drug blocks pancreatic cancer growth
Drug Discovery | News | 0 Comment | 28 Sep, 2018
A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mi...Read more
Drug Discovery | News | 0 Comment | 26 Sep, 2018
Alexion Pharmaceuticals and Syntimmune have entered into a definitive agreement for Alexion to acquire Syntimmune, a cli...Read more